Exact Mass: 506.15681820000003
Exact Mass Matches: 506.15681820000003
Found 56 metabolites which its exact mass value is equals to given mass value 506.15681820000003,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxy-phenyl)-4-(3,4,5-trimethoxy-benzyl)-5H-furan-2-one
2-Propyl-4-pentafluoroethyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole-5-carboxylic acid
Me glycoside,penta-Ac-alpha-Pyranose-3-O-beta-L-Arabinopyranosyl-L-arabinose
Syringic acid methyl ester 4-O-beta-D-apiofuranosyl-(1->2)-beta-D-glucopyranoside|Syringic acid methyl ester-4-O-??-D-apiofuranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside
3,4-methylendioxymethylrocaglate|4-demethoxy-3,4-methylenedioxymethyl rocaglate|Rocaglamide derivative 8
syringic acid 4-O-beta-D-glucopyranosyl-(1?5)-alpha-L-rhamnopyranoside
Me glycoside,penta-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose
Me glycoside,penta-Ac-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-xylose
[(2R,3R,4S,5R,6S)-4,5-dibenzoyloxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl] benzoate
Darifenacin HBr
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Darifenacin hydrobromide (UK-88525 hydrobromide) is a selective M3 muscarinic receptor antagonist with a pKi of 8.9.
C21H30O14_2,3,4,5,6-Pentahydroxycyclohexyl 4-O-(4-hydroxy-2-methoxy-6-methylbenzoyl)hexopyranoside
C21H30O14_4-{[1-(Hexopyranosyloxy)-4-(methoxycarbonyl)-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-6-yl]oxy}-3-hydroxy-4-oxobutanoic acid
Asp Asp Glu Glu
Asp Glu Asp Glu
Asp Glu Glu Asp
Glu Asp Asp Glu
Glu Asp Glu Asp
Glu Glu Asp Asp
[4-(2,4-Dichlorophenyl)-6-dimethylcarbamoylmethyl-2-methyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-3-ylmethyl]carbamic acid tert-butyl ester
18-Crown-5 [4-(2,4-Dinitrophenylazo)phenol]
C22H26N4O10 (506.16488560000005)
METHYL 2,3,4-TRI-O-BENZOYL-ALPHA-D-GLUCOPYRANOSIDE
methyl 2,3,6-tri-o-benzoyl-alpha-d-galactopyranoside
2-[N-(2-acetoxyethyl)-4-chloro-2-nitro-5-[2-(propionamido)anilino]anilino]ethyl acetate
C23H27ClN4O7 (506.15681820000003)
4-fluoro-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide,dihydrochloride
C25H29Cl2FN4O2 (506.16514859999995)
Methyl 2,3,6-tri-O-benzoyl-alpha-D-mannopyranoside
Rovafovir etalafenamide
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
2-Propyl-4-pentafluoroethyl-1-((2-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole-5-carboxylic acid
3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxy-phenyl)-4-(3,4,5-trimethoxy-benzyl)-5H-furan-2-one
2-[(2S,4aR,12aS)-5-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)phenyl]methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-N-[4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]-1,4-dihydroquinoline-3-carboxamide
Ethyl 3-amino-2-(4-methoxybenzoyl)-4-(4-methoxycarbonylphenyl)-6-methyl-4,5-dihydrothieno[2,3-b]pyridine-5-carboxylate
C27H26N2O6S (506.15114960000005)
[(E)-4-[5-[3-[2,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-hydroxy-3-oxopropyl]-2-hydroxyphenyl]-2-methylbut-2-enyl] hydrogen sulate
C25H30O9S (506.16104500000006)